Prosthetic valve endocarditis
- PMID: 6690095
- DOI: 10.1161/01.cir.69.2.223
Prosthetic valve endocarditis
Abstract
Fifty-three (3.6%; actuarially 4.1% at 48 months) of 1465 consecutive in-hospital survivors of valve replacement from 1975 to July 1979 (aortic, mitral, or aortic and mitral, only one untraced) developed prosthetic valve endocarditis (PVE). Incremental risk factors for developing PVE were native valve endocarditis (p less than .0001), black race (p = .0001), mechanical prosthesis (vs bioprosthesis) (p = .005), male sex (p = .04), and longer cardiopulmonary bypass time (p = .09). In general, the hazard function for developing PVE was greatest at 3 weeks after valve replacement. Patients with native valve endocarditis had a tendency to develop PVE early after valve replacement, as did patients in whom mechanical prostheses were used. PVE associated with Staphylococcus epidermidis tended to appear within 6 months of valve replacement, whereas streptococcal PVE tended to appear later after valve replacement. PVE took an atypical form in some patients, but patients with possible PVE (n = 6) had the same findings as those with certain PVE (n = 47). In 11 patients bacteriologic confirmation of PVE was not obtained. The typical prosthetic and periprosthetic characteristics of PVE were present in 30 of the 40 cases in which observations were possible. PVE is a serious condition; 34 (64%) of our 53 patients died. Most deaths occurred within 3 months of the first evidence of PVE. Recovery of some patients is possible with appropriate medical and surgical treatment, but more intense preventive measures are indicated.
Similar articles
-
Comparison between early and late prosthetic valve endocarditis: clinical characteristics and outcomes.J Heart Valve Dis. 2013 Jul;22(4):567-74. J Heart Valve Dis. 2013. PMID: 24224422
-
[Treatment outcome of prosthetic valve endocarditis].Przegl Lek. 2003;60(9):549-52. Przegl Lek. 2003. PMID: 15065330 Polish.
-
Prosthetic valve endocarditis.J Antimicrob Chemother. 1987 Sep;20 Suppl A:173-80. doi: 10.1093/jac/20.suppl_a.173. J Antimicrob Chemother. 1987. PMID: 3316160 Review.
-
[Clinical evaluations of surgical treatment of infective endocarditis].Nihon Kyobu Geka Gakkai Zasshi. 1989 Apr;37(4):600-5. Nihon Kyobu Geka Gakkai Zasshi. 1989. PMID: 2768935 Japanese.
-
[The incidence of endocarditis caused by a prosthetic valve and its risk factors].Orv Hetil. 1989 Apr 9;130(15):765-72. Orv Hetil. 1989. PMID: 2652031 Review. Hungarian.
Cited by
-
Clinical Profiles and Outcomes of Prosthesis-Specific Infective Endocarditis Subsequent to Transcatheter Versus Surgical Aortic Valve Replacement: A Systematic Review and Meta-Analysis.Cureus. 2024 Apr 30;16(4):e59398. doi: 10.7759/cureus.59398. eCollection 2024 Apr. Cureus. 2024. PMID: 38817491 Free PMC article. Review.
-
Streptococcus gallolyticus endocarditis on a prosthetic tricuspid valve: a case report and review of the literature.J Med Case Rep. 2021 Oct 27;15(1):528. doi: 10.1186/s13256-021-03125-5. J Med Case Rep. 2021. PMID: 34702343 Free PMC article. Review.
-
Commentary: The pericardial autologous solution.JTCVS Tech. 2020 Jun 15;3:106-107. doi: 10.1016/j.xjtc.2020.05.029. eCollection 2020 Sep. JTCVS Tech. 2020. PMID: 34317835 Free PMC article. No abstract available.
-
Staphylococcus Auricularis Endocarditis: A Rare Cause of Subacute Prosthetic Valve Endocarditis with Severe Aortic Stenosis.Cureus. 2021 Jan 16;13(1):e12738. doi: 10.7759/cureus.12738. Cureus. 2021. PMID: 33614340 Free PMC article.
-
Mechanical Prosthetic Valve Sparing for Aortic Root Abscess Complicated by Infective Endocarditis.Tex Heart Inst J. 2020 Aug 1;47(4):280-283. doi: 10.14503/THIJ-19-7059. Tex Heart Inst J. 2020. PMID: 33472219 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical